Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

The role of macrophage migration inhibitory factor in autoimmune liver disease.

Assis DN, Leng L, Du X, Zhang CK, Grieb G, Merk M, Garcia AB, McCrann C, Chapiro J, Meinhardt A, Mizue Y, Nikolic-Paterson DJ, Bernhagen J, Kaplan MM, Zhao H, Boyer JL, Bucala R.

Hepatology. 2014 Feb;59(2):580-91. doi: 10.1002/hep.26664. Epub 2013 Dec 20.

2.

A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Assis DN, Takahashi H, Leng L, Zeniya M, Boyer JL, Bucala R.

Dig Dis Sci. 2016 Dec;61(12):3506-3512. Epub 2016 Oct 1.

3.

Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.

Heinrichs D, Knauel M, Offermanns C, Berres ML, Nellen A, Leng L, Schmitz P, Bucala R, Trautwein C, Weber C, Bernhagen J, Wasmuth HE.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17444-9. doi: 10.1073/pnas.1107023108. Epub 2011 Oct 3.

4.

Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis.

Kuai SG, Ou QF, You DH, Shang ZB, Wang J, Liu J, Zhou XK, Pei H, Huang LH.

Infect Dis (Lond). 2016;48(3):222-8. doi: 10.3109/23744235.2015.1107188. Epub 2015 Nov 6.

PMID:
26542751
5.

Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis.

Llamas-Covarrubias MA, Valle Y, Bucala R, Navarro-Hernández RE, Palafox-Sánchez CA, Padilla-Gutiérrez JR, Parra-Rojas I, Bernard-Medina AG, Reyes-Castillo Z, Muñoz-Valle JF.

Cytokine. 2013 Mar;61(3):759-65. doi: 10.1016/j.cyto.2012.12.032. Epub 2013 Feb 9.

6.

Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.

Savva A, Brouwer MC, Roger T, Valls Serón M, Le Roy D, Ferwerda B, van der Ende A, Bochud PY, van de Beek D, Calandra T.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3597-602. doi: 10.1073/pnas.1520727113. Epub 2016 Mar 14.

7.

Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.

Cheng RJ, Deng WG, Niu CB, Li YY, Fu Y.

Int J Gynecol Cancer. 2011 Aug;21(6):1004-12. doi: 10.1097/IGC.0b013e31821c45b7.

PMID:
21792010
8.

Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.

Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL.

J Immunol. 2006 Dec 15;177(12):8730-9.

9.

A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.

Wang FF, Huang XF, Shen N, Leng L, Bucala R, Chen SL, Lu LJ.

Arthritis Res Ther. 2013;15(3):R65.

10.

Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.

Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL.

World J Gastroenterol. 2013 Oct 21;19(39):6656-64. doi: 10.3748/wjg.v19.i39.6656. Review.

11.

[Study on the relationship of CTLA-4 -318, +49 polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in a Chinese population].

Fan LY, Zhu Y, Zhong RQ, Tu XQ, Chen QB, Zhou L, Liu HY, Kong XT.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Oct;21(5):440-3. Chinese.

PMID:
15476165
12.

Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis and type I autoimmune hepatitis.

Eskandari-Nasab E, Tahmasebi A, Hashemi M.

Immunol Invest. 2015;44(4):331-48. doi: 10.3109/08820139.2014.1003651.

PMID:
25942345
13.

[Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population].

Fan LY, Zhong RQ, Tu XQ, Pfeiffer T, Feltens R, Zhu Y, Zhou L.

Zhonghua Gan Zang Bing Za Zhi. 2004 Mar;12(3):160-2. Chinese.

PMID:
15059302
14.

Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.

Xiong C, Huang B, Cun Y, Aghdasi BG, Zhou Y.

Clin Orthop Relat Res. 2014 Jun;472(6):1943-54. doi: 10.1007/s11999-014-3508-y. Epub 2014 Feb 26.

16.

Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese.

Fan LY, Tu XQ, Zhu Y, Pfeiffer T, Feltens R, Stoecker W, Zhong RQ.

World J Gastroenterol. 2005 May 14;11(18):2768-72.

17.

MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.

Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N, Hobeika E, Levit-Zerdoun E, Tenbrock K, Reth M, Bernhagen J, El Bounkari O.

J Immunol. 2014 Jun 1;192(11):5273-84. doi: 10.4049/jimmunol.1302209. Epub 2014 Apr 23.

18.

Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.

Kyriakou DS, Alexandrakis MG, Zachou K, Passam F, Stathakis NE, Dalekos GN.

J Hepatol. 2003 Nov;39(5):679-85.

PMID:
14568247
19.

Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility.

Sadek KH, Ezzat S, Abdel-Aziz SA, Alaraby H, Mosbeh A, Abdel-Rahman MH.

Ann Hum Genet. 2017 Sep;81(5):177-183. doi: 10.1111/ahg.12199. Epub 2017 Jun 28.

PMID:
28657145
20.

Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.

Corallo C, Paulesu L, Cutolo M, Ietta F, Carotenuto C, Mannelli C, Romagnoli R, Nuti R, Giordano N.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S98-105. Epub 2015 May 25.

PMID:
26005773

Supplemental Content

Support Center